{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:49:47Z","timestamp":1791434987219,"version":"4.3.3"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA057540"],"award-info":[{"award-number":["R21DA057540"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019616","name":"Institute for Collaboration on Health, Intervention, and Policy, University of Connecticut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027043","name":"Milken Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022974","name":"Global Alliance for Chronic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21MH117438"],"award-info":[{"award-number":["R21MH117438"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.psychres.2026.117456","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:08:00Z","timestamp":1789427280000},"page":"117456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cognitive effects of ketamine and esketamine treatment for major depressive and bipolar disorder: a systematic review"],"prefix":"10.1016","volume":"366","author":[{"given":"Kelei","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5929-7099","authenticated-orcid":false,"given":"Yealin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Dri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6457-0086","authenticated-orcid":false,"given":"Gia Han","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0928-3433","authenticated-orcid":false,"given":"Sabrina","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-5230","authenticated-orcid":false,"given":"Heidi Ka Ying","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert H.","family":"van Bruggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeho Greg","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0828-0647","authenticated-orcid":false,"given":"Stavroula","family":"Bargiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-4493","authenticated-orcid":false,"given":"Roger","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela T.H","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2026.117456_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114058","article-title":"Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: a comparative, randomized and double-blind study","volume":"303","author":"Ara\u00fajo-de-Freitas","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2026.117456_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.121310","article-title":"The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: a systematic review of systematic reviews and meta-analyses","volume":"402","author":"Ballum","year":"2026","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.psychres.2026.117456_bib0018","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-021-00846-5","article-title":"Prevention and management of common adverse effects of ketamine and esketamine in patients with mood disorders","volume":"35","author":"Ceban","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2026.117456_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2018.07.033","article-title":"Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion","volume":"241","author":"Chen","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2026.117456_bib0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00406-020-01221-z","article-title":"Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients","volume":"271","author":"Chen","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2026.117456_bib0020","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jad.2025.04.119","article-title":"The effects of ketamine and esketamine on measures of quality of life in major depressive disorder and treatment-resistant depression: a systematic review","volume":"382","author":"Cheng","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117456_bib0026","unstructured":"Covidence\u2014Better systematic review management. (2026). Covidence. Retrieved January 8, 2026, from https:\/\/www.covidence.org\/."},{"key":"10.1016\/j.psychres.2026.117456_bib0024","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jad.2020.07.119","article-title":"Neurocognitive impact of ketamine treatment in major depressive disorder: a review on human and animal studies","volume":"276","author":"Crisanti","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"12","key":"10.1016\/j.psychres.2026.117456_bib0052","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jagp.2023.06.016","article-title":"Investigating the effectiveness and tolerability of intranasal esketamine among older adults with treatment-resistant depression (TRD): a post-hoc analysis from the REAL-ESK study group","volume":"31","author":"D\u2019Andrea","year":"2023","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117456_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S109285292610087X","article-title":"Effect of ketamine on reward processing in depressive disorders: a systematic review of neuroimaging studies","volume":"31","author":"Faisal","year":"2026","journal-title":"CNS Spectr."},{"key":"10.1016\/j.psychres.2026.117456_bib0023","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neubiorev.2020.11.020","article-title":"The effects of ketamine on cognition in treatment-resistant depression: a systematic review and priority avenues for future research","volume":"120","author":"Gill","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.psychres.2026.117456_bib0009","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00702-024-02837-4","article-title":"Biomarkers of cognitive and memory decline in psychotropic drug users","volume":"132","author":"Grigore","year":"2025","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.psychres.2026.117456_bib0047","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bdi.12487","article-title":"Ketamine versus midazolam in bipolar depression with suicidal thoughts: a pilot midazolam-controlled randomized clinical trial","volume":"19","author":"Grunebaum","year":"2017","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.psychres.2026.117456_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1681060","article-title":"Comparative safety and tolerability of ketamine and esketamine for major depressive disorder: a systematic review and meta-analysis","volume":"16","author":"Guo","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2026.117456_bib0063","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2215-0366(16)30067-0","article-title":"Selection of cognitive tests for trials of therapeutic agents","volume":"3","author":"Harrison","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2026.117456_bib0019","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jpsychires.2025.10.056","article-title":"The effects of ketamine and esketamine on functional outcomes in major depressive disorder and treatment-resistant depression: a systematic review","volume":"192","author":"Ji","year":"2026","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2026.117456_bib0062","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4196\/kjpp.2008.12.3.101","article-title":"Influence of ketamine on catecholamine secretion in the perfused rat adrenal medulla","volume":"12","author":"Ko","year":"2008","journal-title":"Korean J. Physiol. Pharmacol. Off. J. Korean Physiol. Soc. Korean Soc. Pharmacol."},{"key":"10.1016\/j.psychres.2026.117456_bib0044","doi-asserted-by":"crossref","unstructured":"Kumpf, K.T., Wilkinson S.T., Hu B.o, et al. Comparing the cognitive effects of repeated intravenous ketamine and electroconvulsive therapy in patients with treatment-resistant depression: 2025.","DOI":"10.4088\/JCP.25m15781"},{"issue":"1","key":"10.1016\/j.psychres.2026.117456_bib0056","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/14728222.2026.2619757","article-title":"Modulating tonic NMDA receptor currents: mechanistic insights into ketamine, esketamine, and dextromethorphan for major depressive disorder and implications for the discovery and development of investigational agents","volume":"30","author":"Le","year":"2026","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.psychres.2026.117456_bib0054","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jad.2024.09.081","article-title":"Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: a systematic review","volume":"368","author":"Le","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117456_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2019.08.012","article-title":"Repeated intravenous infusions of ketamine: neurocognition in patients with anxious and nonanxious treatment-resistant depression","volume":"259","author":"Liu","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2026.117456_bib0001","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/wps.20771","article-title":"The clinical characterization of the adult patient with depression aimed at personalization of management","volume":"19","author":"Maj","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2026.117456_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1011103","article-title":"The effect of ketamine on cognition, anxiety, and social functioning in adults with psychiatric disorders: a systematic review and meta-analysis","volume":"16","author":"Marchi","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psychres.2026.117456_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2024.02.052","article-title":"Cognitive outcomes from the randomised, active-controlled ketamine for adult depression study (KADS)","volume":"352","author":"Martin","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2026.117456_bib0002","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/wps.20997","article-title":"The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management","volume":"21","author":"McIntyre","year":"2022","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117456_bib0004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117456_bib0003","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"issue":"10265","key":"10.1016\/j.psychres.2026.117456_bib0008","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.psychres.2026.117456_bib0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/da.22063","article-title":"Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions","volume":"30","author":"McIntyre","year":"2013","journal-title":"Depress. Anxiety"},{"issue":"10","key":"10.1016\/j.psychres.2026.117456_bib0013","doi-asserted-by":"crossref","first-page":"pyw055","DOI":"10.1093\/ijnp\/pyw055","article-title":"The effects of vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials","volume":"19","author":"McIntyre","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.psychres.2026.117456_bib0057","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40263-024-01114-y","article-title":"Glutamatergic modulators for major depression from theory to clinical use","volume":"38","author":"McIntyre","year":"2024","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.psychres.2026.117456_bib0012","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1017\/S1461145714000546","article-title":"A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults","volume":"17","author":"McIntyre","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2026.117456_bib0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117456_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113993","article-title":"The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: results from the canadian rapid treatment center of excellence (CRTCE)","volume":"302","author":"McIntyre","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2026.117456_bib0064","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.euroneuro.2023.06.006","article-title":"Neuropsychological functioning of patients with major depression or bipolar disorder comorbid to substance use disorders: a systematic review","volume":"75","author":"Miguel","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2026.117456_bib0007","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bdi.12595","article-title":"Assessing and addressing cognitive impairment in bipolar disorder: the international society for bipolar disorders targeting cognition task force recommendations for clinicians","volume":"20","author":"Miskowiak","year":"2018","journal-title":"Bipolar Disord."},{"issue":"11","key":"10.1016\/j.psychres.2026.117456_bib0046","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyae046","article-title":"Effect of esketamine nasal spray on cognition in patients with treatment-resistant depression: results from four phase 3 studies","volume":"27","author":"Morrison","year":"2024","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2026.117456_bib0032","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00213-013-3255-x","article-title":"Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response","volume":"231","author":"Murrough","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2026.117456_bib0025","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.psychres.2026.117456_bib0033","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/ijnp\/pyac045","article-title":"Assessment of objective and subjective cognitive function in patients with treatment-resistant depression undergoing repeated ketamine infusions","volume":"25","author":"Phillips","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2026.117456_bib0014","series-title":"StatPearls","article-title":"Ketamine","author":"Rosenbaum","year":"2025"},{"key":"10.1016\/j.psychres.2026.117456_bib0034","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jad.2020.08.058","article-title":"Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression","volume":"277","author":"Shiroma","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117456_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115829","article-title":"Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial","volume":"335","author":"Singh","year":"2024","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.psychres.2026.117456_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/ph18020173","article-title":"Long-term cognitive outcomes of esketamine nasal spray in treatment-resistant depression: a preliminary report","volume":"18","author":"Sobreiro","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.psychres.2026.117456_bib0027","first-page":"i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.psychres.2026.117456_bib0029","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jpsychires.2021.02.028","article-title":"Ketamine specifically reduces cognitive symptoms in depressed patients: an investigation of associated neural activation patterns","volume":"136","author":"Stippl","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2026.117456_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2022.795231","article-title":"Brain changes associated with long-term ketamine abuse, a systematic review","volume":"16","author":"Strous","year":"2022","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.psychres.2026.117456_bib0028","unstructured":"\u201cStudy Quality Assessment Tools | NHLBI, NIH.\u201d Accessed February 9, 2026. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"issue":"1","key":"10.1016\/j.psychres.2026.117456_bib0051","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jagp.2025.08.001","article-title":"Ketamine and esketamine for late-life depression: a systematic review of efficacy, safety, and tolerability","volume":"34","author":"Sukhdeo","year":"2025","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117456_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852921000092","article-title":"Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials","author":"Tamura","year":"2021","journal-title":"CNS Spectr."},{"issue":"6","key":"10.1016\/j.psychres.2026.117456_bib0011","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S1092852924002293","article-title":"The mediational role of cognitive function on occupational outcomes in persons with major depressive and bipolar disorder","volume":"29","author":"Tamura","year":"2024","journal-title":"CNS Spectr."},{"issue":"6","key":"10.1016\/j.psychres.2026.117456_bib0006","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S1092852924002293","article-title":"The mediational role of cognitive function on occupational outcomes in persons with major depressive and bipolar disorder","volume":"29","author":"Tamura","year":"2024","journal-title":"CNS Spectr."},{"key":"10.1016\/j.psychres.2026.117456_bib0017","doi-asserted-by":"crossref","DOI":"10.1080\/14740338.2026.2627184","article-title":"Are the current safety measures for the treatment of depression with esketamine sufficient?","author":"Valentino","year":"2026","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.psychres.2026.117456_bib0021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.euroneuro.2024.12.013","article-title":"Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study","volume":"93","author":"Vieta","year":"2025","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2026.117456_bib0059","first-page":"241","article-title":"Functional connectivity between glutamate receptor antagonism and insulin pathways: implications for modeling mechanism of action of ketamine\/esketamine and dextromethorphan in depression treatment","volume":"10","author":"Wong","year":"2025","journal-title":"Biol. Psychiatry: Cogn. Neurosci. Neuroimaging Metab. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2026.117456_bib0058","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000549276","article-title":"A systematic review of the effects of N-Methyl-D-aspartate receptor antagonists on pancreatic islets","volume":"116","author":"Wong","year":"2026","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psychres.2026.117456_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2026.104870","article-title":"Molecular evidence associating GLP-1 receptor agonists and brain-derived neurotrophic factors in neurodegenerative and psychiatric disorders: a systematic review","volume":"117","author":"Xu","year":"2026","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.psychres.2026.117456_bib0038","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jad.2024.09.162","article-title":"Effects of subanesthetic repeated esketamine infusions on memory function and NGF in patients with depression: an open-label study","volume":"369","author":"Yang","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117456_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1227879","article-title":"Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment","volume":"14","author":"Zavaliangos-Petropulu","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117456_bib0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2023.04.015","article-title":"Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression","volume":"333","author":"Zavaliangos-Petropulu","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117456_bib0041","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jad.2018.12.005","article-title":"Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder","volume":"246","author":"Zheng","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117456_bib0042","article-title":"Cognitive function mediates the anti-suicide effect of repeated intravenous ketamine in adult patients with suicidal ideation","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117456_bib0043","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jad.2022.02.032","article-title":"The effectiveness of repeated intravenous ketamine on subjective and objective psychosocial function in patients with treatment-resistant depression and suicidal ideation","volume":"304","author":"Zhou","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.psychres.2026.117456_bib0050","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0269881118798614","article-title":"Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression","volume":"32","author":"Zhou","year":"2018","journal-title":"J. Psychopharmacol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126005160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126005160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:05:14Z","timestamp":1791432314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126005160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":64,"alternative-id":["S0165178126005160"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117456","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive effects of ketamine and esketamine treatment for major depressive and bipolar disorder: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117456"}}